In the News

Cebix is proud to announce our new Chief Medical Officer, Howard Foyt.

Howard Foyt, M.D., Ph.D., FACP, has served as Senior Vice President and Chief Medical Officer at Cebix, Inc. since April 2011. Dr. Foyt previously was Vice President, Clinical Development at Metabasis Therapeutics, which he joined from Pfizer Global Research & Development where he served as Senior Director, Medical & Development Sciences and Therapy Area Site Head—Diabetes & Obesity. He began his industry career over fifteen years ago at Parke-Davis Pharmaceutical Research, Ann Arbor, MI where he was Director, Clinical Research, Endocrine and Metabolism prior to the acquisition of the company by Pfizer. Prior to joining Parke-Davis, Dr. Foyt was an Assistant Professor and Medical Director, University Diabetes Center at the University of Texas Medical Branch, Galveston, TX. He earned his medical degree in 1985 from Baylor College of Medicine where he also earned a Ph.D. in Cell Biology. Dr. Foyt completed his residency in internal medicine at Baylor and an endocrinology fellowship at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.